Save up to 30% on Elsevier print and eBooks with free shipping. No promo code needed.
Save up to 30% on print and eBooks.
Side Effects of Drugs Annual
A Worldwide Yearly Survey of New Data and Trends in Adverse Drug Reactions
1st Edition, Volume 30 - July 3, 2008
Editor: Jeffrey K. Aronson
Language: English
Hardback ISBN:9780444527677
9 7 8 - 0 - 4 4 4 - 5 2 7 6 7 - 7
eBook ISBN:9780080931517
9 7 8 - 0 - 0 8 - 0 9 3 1 5 1 - 7
The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effe…Read more
Purchase options
LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has contributed to the informative, by critically interpreting it, and by pointing to whatever is misleading.
Provides a critical yearly survey of new data and trends in the side effects of drugs
Each drug article contains case histories
Contains detailed information on drug-drug interactions
Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, clinical pharmacologists and medical libraries
Contributors Special Reviews Cumulative Index of Special Reviews, Annuals 13 – 29 DoTS Classification of Adverse Drug Reactions How to use this book ESSAYS: Central nervous system stimulants and drugs that suppress appetite Antidepressant drugs Lithium Drugs of abuse Hypnotics and sedatives Antipsychotic drugs Antiepileptic drugs Opioid analgesics and narcotic antagonists Anti-inflammatory and antipyretic analgesics and drugs used in gout General anesthetics and therapeutic gases Local anesthetics Neuromuscular blocking agents and skeletal muscle relaxants Drugs that affect autonomic functions or the extrapyramidal system Dermatological drugs, topical agents and cosmetics Antihistamines (H1 receptor antagonists) Drugs acting on the respiratory tract Positive inotropic drugs and drugs used in dysrhythmias Beta-adrenoceptor antagonists and antianginal drugs Drugs acting on the cerebral and peripheral circulations Antihypertensive drugs Diuretics Metals Metal antagonists Antiseptic drugs and disinfectants Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines Miscellaneous antibacterial drugs Antifungal drugs Antiprozotoal Drugs Antiviral drugs Drugs used in tuberculosis and leprosy Antihelminthic drugs Vaccines Blood, blood components, plasma and plasma products Formulations used in nutrition Drugs affecting blood coagulation, fibrinolysis, and hemostasis Gastrointestinal drugs Drugs that act on the immune system: cytokines and monoclonal antibodies Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs Corticotrophins, corticosteroids, and prostaglandins Sex hormones and related compounds, including hormonal contraceptives Thyroid hormones, iodine, and antithyroid drugs Insulin, other hypoglycemic drugs, and glucagon Miscellaneous hormones Drugs that affect lipid metabolism Cytostatic drugs Radiological contrast agents Drugs used in ocular treatment Treatments used in complementary and alternative medicine Miscellaneous drugs and materials, medical devices and techniques
No. of pages: 672
Language: English
Edition: 1
Volume: 30
Published: July 3, 2008
Imprint: Elsevier Science
Hardback ISBN: 9780444527677
eBook ISBN: 9780080931517
JA
Jeffrey K. Aronson
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.
Affiliations and expertise
consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust